000 | 01972 a2200505 4500 | ||
---|---|---|---|
005 | 20250515005243.0 | ||
264 | 0 | _c20060503 | |
008 | 200605s 0 0 eng d | ||
022 | _a0306-4522 | ||
024 | 7 |
_a10.1016/j.neuroscience.2005.09.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeonetti, M | |
245 | 0 | 0 |
_a2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission. _h[electronic resource] |
260 |
_bNeuroscience _c2006 |
||
300 |
_a555-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAmygdala _xphysiology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzamides _xpharmacology |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 | _aElectric Stimulation |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 |
_aExtracellular Fluid _xdrug effects |
650 | 0 | 4 |
_aGlutamic Acid _xmetabolism |
650 | 0 | 4 |
_aGlycine _xmetabolism |
650 | 0 | 4 |
_aGlycine Plasma Membrane Transport Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMicrodialysis |
650 | 0 | 4 |
_aNeural Pathways _xphysiology |
650 | 0 | 4 |
_aNucleus Accumbens _xdrug effects |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPresynaptic Terminals _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, AMPA _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
700 | 1 | _aDesvignes, C | |
700 | 1 | _aBougault, I | |
700 | 1 | _aSouilhac, J | |
700 | 1 | _aOury-Donat, F | |
700 | 1 | _aSteinberg, R | |
773 | 0 |
_tNeuroscience _gvol. 137 _gno. 2 _gp. 555-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2005.09.003 _zAvailable from publisher's website |
999 |
_c15914084 _d15914084 |